Literature DB >> 22109552

FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors.

Anna C Calkin1, Benjamin T Goult, Li Zhang, Louise Fairall, Cynthia Hong, John W R Schwabe, Peter Tontonoz.   

Abstract

The E3 ubiquitin ligase IDOL (inducible degrader of the LDL receptor) regulates LDL receptor (LDLR)-dependent cholesterol uptake, but its mechanism of action, including the molecular basis for its stringent specificity, is poorly understood. Here we show that IDOL uses a singular strategy among E3 ligases for target recognition. The IDOL FERM domain binds directly to a recognition sequence in the cytoplasmic tails of lipoprotein receptors. This physical interaction is independent of IDOL's really interesting new gene (RING) domain E3 ligase activity and its capacity for autoubiquitination. Furthermore, IDOL controls its own stability through autoubiquitination of a unique FERM subdomain fold not present in other FERM proteins. Key residues defining the IDOL-LDLR interaction and IDOL autoubiquitination are functionally conserved in their insect homologs. Finally, we demonstrate that target recognition by IDOL involves a tripartite interaction between the FERM domain, membrane phospholipids, and the lipoprotein receptor tail. Our data identify the IDOL-LDLR interaction as an evolutionarily conserved mechanism for the regulation of lipid uptake and suggest that this interaction could potentially be exploited for the pharmacologic modulation of lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22109552      PMCID: PMC3250164          DOI: 10.1073/pnas.1111589108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain.

Authors:  M A Pearson; D Reczek; A Bretscher; P A Karplus
Journal:  Cell       Date:  2000-04-28       Impact factor: 41.582

Review 2.  The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein.

Authors:  H H Hobbs; D W Russell; M S Brown; J L Goldstein
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

Review 3.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

4.  The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.

Authors:  Daphna Weissglas-Volkov; Anna C Calkin; Teresa Tusie-Luna; Janet S Sinsheimer; Noam Zelcer; Laura Riba; Ana Maria Vargas Tino; Maria Luisa Ordoñez-Sánchez; Ivette Cruz-Bautista; Carlos A Aguilar-Salinas; Peter Tontonoz; Päivi Pajukanta
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

5.  The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor.

Authors:  H Tolleshaug; K K Hobgood; M S Brown; J L Goldstein
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

6.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Authors:  Marianne Abifadel; Mathilde Varret; Jean-Pierre Rabès; Delphine Allard; Khadija Ouguerram; Martine Devillers; Corinne Cruaud; Suzanne Benjannet; Louise Wickham; Danièle Erlich; Aurélie Derré; Ludovic Villéger; Michel Farnier; Isabel Beucler; Eric Bruckert; Jean Chambaz; Bernard Chanu; Jean-Michel Lecerf; Gerald Luc; Philippe Moulin; Jean Weissenbach; Annick Prat; Michel Krempf; Claudine Junien; Nabil G Seidah; Catherine Boileau
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

7.  Functional activities and cellular localization of the ezrin, radixin, moesin (ERM) and RING zinc finger domains in MIR.

Authors:  Beat C Bornhauser; Cecilia Johansson; Dan Lindholm
Journal:  FEBS Lett       Date:  2003-10-09       Impact factor: 4.124

8.  ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2.

Authors:  Guocheng He; Sarita Gupta; Ming Yi; Peter Michaely; Helen H Hobbs; Jonathan C Cohen
Journal:  J Biol Chem       Date:  2002-09-08       Impact factor: 5.157

9.  Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.

Authors:  Kara N Maxwell; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

10.  SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element.

Authors:  X Hua; C Yokoyama; J Wu; M R Briggs; M S Brown; J L Goldstein; X Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more
  21 in total

Review 1.  Cargo recognition in clathrin-mediated endocytosis.

Authors:  Linton M Traub; Juan S Bonifacino
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

2.  AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia.

Authors:  Suryanarayan Somanathan; Frank Jacobs; Qiang Wang; Alexandra L Hanlon; James M Wilson; Daniel J Rader
Journal:  Circ Res       Date:  2014-07-14       Impact factor: 17.367

Review 3.  Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.

Authors:  Li Zhang; Karen Reue; Loren G Fong; Stephen G Young; Peter Tontonoz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-30       Impact factor: 8.311

4.  The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice.

Authors:  Cynthia Hong; Stephanie M Marshall; Allison L McDaniel; Mark Graham; Joseph D Layne; Lei Cai; Elena Scotti; Rima Boyadjian; Jason Kim; Brian T Chamberlain; Rajendra K Tangirala; Michael E Jung; Loren Fong; Richard Lee; Stephen G Young; Ryan E Temel; Peter Tontonoz
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

Review 5.  Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.

Authors:  Anna C Calkin; Peter Tontonoz
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-14       Impact factor: 94.444

6.  IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.

Authors:  Elena Scotti; Martino Calamai; Chris N Goulbourne; Li Zhang; Cynthia Hong; Ron R Lin; Jinkuk Choi; Paul F Pilch; Loren G Fong; Peng Zou; Alice Y Ting; Francesco S Pavone; Stephen G Young; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

Review 7.  Liver X receptors in lipid signalling and membrane homeostasis.

Authors:  Bo Wang; Peter Tontonoz
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

8.  A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis.

Authors:  Karin E Bornfeldt; Farah Kramer; Anna Batorsky; Jinkuk Choi; Kelly L Hudkins; Peter Tontonoz; Charles E Alpers; Jenny E Kanter
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

Review 9.  Liver X receptors in lipid metabolism: opportunities for drug discovery.

Authors:  Cynthia Hong; Peter Tontonoz
Journal:  Nat Rev Drug Discov       Date:  2014-05-16       Impact factor: 84.694

10.  The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis.

Authors:  Jinkuk Choi; Jie Gao; Jaekwang Kim; Cynthia Hong; Jungsu Kim; Peter Tontonoz
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.